ERIKA SACHAU: Open Payments
NPI 1265434906 · PAPILLION, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 17 payments from 9 companies in 2025. Trend: 2023 $406 · 2024 $462 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 3 | $55 |
| Astellas Pharma US Inc | 2 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $45 |
| Smith+Nephew, Inc. | 1 | $44 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Organon LLC | 1 | $22 |
| Exeltis, USA Inc. | 1 | $15 |
Products named: ZURZUVAE, Veozah, MYFEMBREE, LILETTA, GRAFIX PL, Mirena, NEXPLANON, SLYND.
Industry payments across NE — which companies pay providers there.
